{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T09:58:25Z","timestamp":1781344705641,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07000-5","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:34:11Z","timestamp":1778157251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of interleukin-1 beta as an early biomarker for renal dysfunction in Egyptian sickle cell disease patients"],"prefix":"10.1007","volume":"105","author":[{"given":"Nourhan Mohamed","family":"Nasr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha Khalifa Abd El","family":"Ghaffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaimaa Mohamed","family":"El Asmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin Mohamed","family":"Saber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"7000_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-pathmechdis-012418-012838","volume":"14","author":"P Sundd","year":"2019","unstructured":"Sundd P, Gladwin MT, Novelli EM . (2019) . Pathophysiology of Sickle Cell Disease. Annu Rev Pathol 14:263\u2013292. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-012418-012838","journal-title":"Annu Rev Pathol"},{"key":"7000_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2165\/00128072-200204010-00004","volume":"4","author":"L de Santis Feltran","year":"2002","unstructured":"de Santis Feltran L, de Abreu Carvalhaes JT, Sesso R .(2002) . Renal complications of sickle cell disease:Managing for optimal outcomes. Paediatr Drugs 4:29\u201336. https:\/\/doi.org\/10.2165\/00128072-200204010-00004","journal-title":"Paediatr Drugs"},{"key":"7000_CR3","doi-asserted-by":"publisher","first-page":"614","DOI":"10.7326\/0003-4819-115-8-614","volume":"115","author":"DR Powars","year":"1991","unstructured":"Powars DR, Elliott-Mills DD, Chan L et al ., (1991) .Chronic renal failure in sickle cell disease: Risk factors,clinical course, and mortality. Ann Intern Med 115:614\u2013620. https:\/\/doi.org\/10.7326\/0003-4819-115-8-614","journal-title":"Ann Intern Med"},{"key":"7000_CR4","doi-asserted-by":"publisher","unstructured":"Hiti AL, Zeng L, Xiang Q et al (1997) Beta-globin haplotypes from blood spots for follow-up of newbornhemoglobinopathy screening. 54:76\u201378. https:\/\/doi.org\/10.1002\/(sici)1096-8652(199701)54:1%3C76::aid-ajh12%3E3.0.co;2-8","DOI":"10.1002\/(sici)1096-8652(199701)54:1%3C76::aid-ajh12%3E3.0.co;2-8"},{"key":"7000_CR5","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1046\/j.1523-1755.2002.00363.x","volume":"61","author":"DE Wesson","year":"2002","unstructured":"Wesson DE (2002) . The initiation and progression of sickle cell nephropathy. Kidney Int 61:2277\u20132286. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00363.x","journal-title":"Kidney Int"},{"key":"7000_CR6","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00467-006-0033-6","volume":"21","author":"O Alvarez","year":"2006","unstructured":"Alvarez O, Zilleruelo G, Wright D et al ., (2006) . Serum cystatin C levels in children with sickle cell disease. Pediatr Nephrol 21:533\u2013537. https:\/\/doi.org\/10.1007\/s00467-006-0033-6","journal-title":"Pediatr Nephrol"},{"key":"7000_CR7","doi-asserted-by":"publisher","unstructured":"Levey AS, Eckardt KU, Tsukamoto Y et al ., (2005) . Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).Kidney Int. 67:2089\u20132100. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00365.x","DOI":"10.1111\/j.1523-1755.2005.00365.x"},{"issue":"1","key":"7000_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5409\/wjcp.v11.i1.14","volume":"11","author":"YS Osama","year":"2022","unstructured":"Osama YS, Rana MB, Sereen AA et al ., (2022) . Sickle cell nephropathy: A review of novel biomarkers and their potential roles in early detection of renal involvement World. J Clin Pediatr 11(1):14\u201326. https:\/\/doi.org\/10.5409\/wjcp.v11.i1.14","journal-title":"J Clin Pediatr"},{"issue":"8","key":"7000_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s002770000173","volume":"79","author":"AC Makis","year":"2000","unstructured":"Makis AC, Hatzimichael EC, Bourantas KL . (2000) . The role of cytokines in sickle cell disease. Ann Hematol 79(8):407\u2013413. https:\/\/doi.org\/10.1007\/s002770000173","journal-title":"Ann Hematol"},{"issue":"4","key":"7000_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/ajh.20196","volume":"77","author":"A Pathare","year":"2004","unstructured":"Pathare A, Al Kindi S, Alnaqdy AA, Daar S, Knox-Macaulay H, Dennison D . (2004) . Cytokine profile of sickle cell disease in Oman. Am J Hematol 77(4):323\u2013328. https:\/\/doi.org\/10.1002\/ajh.20196","journal-title":"Am J Hematol"},{"issue":"1","key":"7000_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cyto.2009.10.002","volume":"49","author":"BE Asare k, Gee","year":"2009","unstructured":"Asare k, Gee BE, Stiles JK et al .,(2009) . Plasma interleukin-1\u03b2 concentration is associated with stroke in sickle cell disease. Cytokine 49(1):39\u201344. https:\/\/doi.org\/10.1016\/j.cyto.2009.10.002","journal-title":"Cytokine"},{"key":"7000_CR12","doi-asserted-by":"crossref","unstructured":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease Kidney International 105 (4S), S117\u2013S314 .","DOI":"10.1016\/j.kint.2023.10.018"},{"issue":"1","key":"7000_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1182\/blood-2020-140756","volume":"136","author":"A Oladapo","year":"2020","unstructured":"Oladapo A, Swallow E, Briggs A et al ., (2020) . Prevalence of Vaso-Occlusive Crises in Patients with Sickle Cell Disease: A Retrospective US Claims Database Analysis. Blood 136(1):8\u20139. https:\/\/doi.org\/10.1182\/blood-2020-140756","journal-title":"Blood"},{"key":"7000_CR14","doi-asserted-by":"publisher","unstructured":"Ilesanmi OO . (2010) . Pathological basis of symptoms and crises in sickle cell disorder: implications for counseling and psychotherapy. Hematol Rep 2(1):e2\u2013e2. https:\/\/doi.org\/10.4081\/hr.2010.e2","DOI":"10.4081\/hr.2010.e2"},{"key":"7000_CR15","doi-asserted-by":"publisher","unstructured":"Eduard J, Beers V, Yang Y et al .,(2015) . Iron, Inflammation, and Early Death in Adults With Sickle Cell Disease. Circulation Research. , 116 (2), 298\u2013306. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.304577","DOI":"10.1161\/CIRCRESAHA.116.304577"},{"key":"7000_CR16","doi-asserted-by":"publisher","unstructured":"Derebail VK, Zhou Q, Ciccone EJ et al ., (2021) . Longitudinal study of glomerular hyperfiltration and normalization of estimated glomerular filtration in adults with sickle cell disease. Br J Haematol , 195(1), 123\u2013132. https:\/\/doi.org\/10.1111\/bjh.17723","DOI":"10.1111\/bjh.17723"},{"issue":"13","key":"7000_CR17","doi-asserted-by":"publisher","first-page":"e262","DOI":"10.1161\/CIR.0000000000000440","volume":"134","author":"DR Young","year":"2016","unstructured":"Young DR, Hivert MF, Alhassan S et al ., (2016) . Sedentary behavior and cardiovascular morbidity and mortality: a science advisory from the American Heart Association. Circulation 134(13):e262\u2013e279. https:\/\/doi.org\/10.1161\/CIR.0000000000000440","journal-title":"Circulation"},{"key":"7000_CR18","doi-asserted-by":"publisher","unstructured":"Ataga KI, Derebail VK, Archer DR . (2014) .The glomerulopathy of sickle cell disease. Am J Hematol 89(9):907\u2013914. https:\/\/doi.org\/10.1002\/ajh.23762","DOI":"10.1002\/ajh.23762"},{"issue":"8","key":"7000_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s002770000173","volume":"79","author":"AC Makis","year":"2000","unstructured":"Makis AC, Hatzimichael EC, Bourantas KL . (2000) . The role of cytokines in sickle cell disease. Ann Hematol 79(8):407\u2013413. https:\/\/doi.org\/10.1007\/s002770000173","journal-title":"Ann Hematol"},{"issue":"10","key":"7000_CR20","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1182\/bloodadvances.2022008006","volume":"94","author":"SL Saraf","year":"2019","unstructured":"Saraf SL, Zhang X, Shah B et al . , (2019) . Urine biomarkers and renal outcomes in sickle cell disease. Am J Hematol 94(10):1106\u20131114. https:\/\/doi.org\/10.1182\/bloodadvances.2022008006","journal-title":"Am J Hematol"},{"key":"7000_CR21","doi-asserted-by":"publisher","unstructured":"Liao X, Xiao Y, Elbelt U et al ., (2022) . Association of Interleukin-1 Beta and Interleukin-1 Receptor Antagonist Gene Polymorphisms and Plasma Levels with Diabetic Nephropathy. Biomed Res Int 7. https:\/\/doi.org\/10.1155\/2022\/9661823","DOI":"10.1155\/2022\/9661823"},{"issue":"8","key":"7000_CR22","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00467-008-1046-0","volume":"24","author":"DM Silverstein","year":"2009","unstructured":"Silverstein DM. (2009).Inflammation in chronic kidney disease : role in the progression of renal and cardiovascular disease. Pediatr Nephrol. ;24(8):1445\u20131452. https:\/\/doi.org\/10.1007\/s00467-008-1046-0","journal-title":"Pediatr Nephrol"},{"key":"7000_CR23","doi-asserted-by":"publisher","unstructured":"Naik RP, and Derebail VK .(2017) .The spectrum of sickle hemoglobin\u2013related nephropathy: from hyperfiltration to chronic kidney disease. Expert Rev Hematol ; 10(12): 1087\u20131094. https:\/\/doi.org\/10.1080\/17474086.2017.1395279","DOI":"10.1080\/17474086.2017.1395279"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07000-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07000-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07000-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T09:48:21Z","timestamp":1781344101000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07000-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":23,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["7000"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07000-5","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"31 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Each subject provided written informed permission. The 18th World Medical Assembly in Helsinki, Finland, enacted the Institutional Committee regulations for the Protection of Human Subjects, which were followed in this study. The study protocol was submitted to the Fayoum University Ethical Committee for approval under code number (R 703).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"287"}}